Friday, 17 May 2019
A recent study found that people who walk at faster paces may live longer than people who walk slower. The data was self-reported by nearly 475,000 people in the UK, revealing that this increased physical activity’s longevity benefit persisted despite the person’s body weight. The findings underscore the importance of getting adequate levels of physical activity.
Of all the people evaluated, the study found that underweight individuals who reported walking at slow paces had the lowest life expectancy: an average of 64.8 years for men and 72.4 years for women. The association pertains to people who ‘habitually’ walk at faster paces rather than people who just sometimes speed walk.
At the heart of the matter is physical activity, which is known to offer a number of health benefits. This is the first study a looked specifically at typical walking speeds and how it correlates to life expectancy; the information was self-reported by the participants.
1. Emotional loneliness
Emotional loneliness is not circumstantial but, rather, comes from within.
2. Situational loneliness
Situational loneliness can result from being in circumstances that make developing friendships difficult.
3. Social loneliness
Social loneliness is typically experienced by those who have problems in social situations because of shyness, social awkwardness, or a sense of low self-esteem.
4. Chronic loneliness
Chronic loneliness is the term used to describe those who have been lonely for so long that it has become a way of life to them.
Read more on how to beat them @ https://www.stylist.co.uk/long-reads/how-to-deal-with-loneliness-types-emotional-situational-social-chronic/222923
|Image for illustration only|
The world's first drugs designed to stop cancer cells becoming resistant to treatment could be available within the next decade, scientists have said.
A £75m investment to develop the drugs has been announced by the Institute of Cancer Research (ICR).
Chief executive Prof Paul Workman said cancer's ability to adapt to drugs is the biggest challenge in treatment.
The new drugs could make cancer a "manageable" disease in the long term and "more often curable", he said.